Ateganosine (THIO, 6-thio-2'-deoxyguanosine), a first-in-class telomere-targeting therapy under development by MAIA ...
PRESS RELEASEAB SCIENCE ANNOUNCES NEW PUBLICATION ON MEDRXIV HIGHLIGHTING CLINICAL BENEFIT WITH MASITINIB IN AMYOTROPHIC LATERAL SCLEROSIS ...
Roche’s data on Wednesday come from the Phase III lidERA Breast Cancer study, which assessed the adjuvant use of giredestrant ...
House Democrats join Republicans to defeat Rep. Al Green's Trump impeachment effort in bipartisan vote, showing a limited ...
Venezuela's Maduro vows to "smash teeth" of the U.S. after America seized an oil tanker off the Venezuelan coast, escalating ...
In chronic spontaneous urticaria, InflaRx observed substantial reductions in the 7-day Urticaria Activity Score (UAS7) broadly across patients and particularly in those with severe disease, as well as ...
Eli Lilly said on Thursday its next-generation obesity drug helped patients lose an average of 28.7% of their weight in a ...
Chronic Pruritus of Unknown Origin (CPUO) is characterized by a persistent, chronic itch with an unknown cause and is associated with very high burden of disease due to severe itch, sleep deprivation ...
The Company’s lead CAPTN-3 program, IM1240, demonstrated significant anti-tumor activity in three PD1–resistant ex-vivo models, including new results in HNSCC patient-derived biopsies. In these ...
Inotiv, Inc. (NASDAQ: NOTV) (the 'Company”, or 'Inotiv”), a leading Contract Research Organization (CRO) specializing in nonclinical and analytical drug discovery and development services and research ...
Pancreatic cancer is one of the deadliest malignancies, with survival rates remaining dismally low despite major advances in ...
Discover how in silico tools can be used can be used with organ-on-a-chip for the advancement of ADME studies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback